SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-037289
Filing Date
2022-02-11
Accepted
2022-02-11 16:57:00
Documents
1
Group Members
NEW LEAF BPO ASSOCIATES I, L.P.NEW LEAF VENTURE ASSOCIATES IV, L.P.NEW LEAF VENTURE MANAGEMENT III, L.L.C.NEW LEAF VENTURE MANAGEMENT IV, L.L.CNEW LEAF VENTURES IV, L.P.RONALD HUNTVIJAY LATHI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d290384dsc13ga.htm SC 13G/A 144420
  Complete submission text file 0001193125-22-037289.txt   146524
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Subject) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89009 | Film No.: 22622269
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Biopharma Opportunities I, L.P. (Filed by) CIK: 0001625696 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A